1959New England Journal of MedicineRequires access

Lupus Erythematosus Treated with a Combination of Quinacrine, Hydroxychloroquine and Chloroquine*

Mauray J. Tye, Herbert White, Bernard Appel, Harvey B. Ansell

Open publisher page 43 citations

Abstract

THIS study was undertaken as a clinical evaluation of the treatment of lupus erythematosus with a tablet composed of quinacrine, 25 mg., hydroxychloroquine, 50 mg., and chloroquine, 65 mg.¶ Certain antimalarial drugs have been shown to be more effective than any therapy previously available in treatment of chronic discoid lupus erythematosus. The literature on the use of quinacrine,1 , 2 hydroxychloroquine3 , 4 and chloroquine5 is already extensive. We have studied therapeutic and maintenance doses, relapses and side effects of this combination.The action of and the rationale for the use of these antimalarial drugs in lupus erythematosus have been the subject of some . . .

About this research paper

What this paper is about

THIS study was undertaken as a clinical evaluation of the treatment of lupus erythematosus with a tablet composed of quinacrine, 25 mg., hydroxychloroquine, 50 mg., and chloroquine, 65 mg.¶ Certain antimalarial drugs have been shown to be more effective than any therapy previously available in treatment of chronic discoid lupus erythematosus. The literature on the use of quinacrine,1 , 2 hydroxychloroquine3 , 4 and chloroquine5 is already extensive. We have studied therapeutic and maintenance doses, relapses and side effects of this combination.The action of and the rationale for the use of these antimalarial drugs in lupus erythematosus have been the subject of some . . .

Why it matters

OpenAlex reports 43 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

THIS study was undertaken as a clinical evaluation of the treatment of lupus erythematosus with a tablet composed of quinacrine, 25 mg., hydroxychloroquine, 50 mg., and chloroquine, 65 mg.¶ Certain antimalarial drugs have been shown to be more effective than any therapy previously available in treatment of chronic discoid lupus erythematosus. The literature on the use of quinacrine,1 , 2 hydroxychloroquine3 , 4 and chloroquine5 is already extensive. We have studied therapeutic and maintenance doses, relapses and side effects of this combination.The action of and the rationale for the use of these antimalarial drugs in lupus erythematosus have been the subject of some . . .

Key concepts: Hydroxychloroquine, Chloroquine, Medicine, Lupus erythematosus, Antimalarial Agent, Dermatology, Systemic lupus erythematosus, Discoid lupus erythematosus

Related papers

Back to paper searchBrowse research topicsOriginal source
Lupus Erythematosus Treated with a Combination of Quinacrine, Hydroxychloroquine and Chloroquine* — Research Paper | ScholarLens